The permeability transition pore complex:: A target for apoptosis regulation by caspases and Bcl-2-related proteins

被引:582
|
作者
Marzo, I
Brenner, C
Zamzami, N
Susin, SA
Beutner, G
Brdiczka, D
Rémy, R
Xie, ZH
Reed, JC
Kroemer, G
机构
[1] CNRS, Unite Propre Rech 420, F-94801 Villejuif, France
[2] Univ Konstanz, Fac Biol, D-78434 Konstanz, Germany
[3] Univ Paris 11, CNRS, F-91405 Orsay, France
[4] Burnham Inst, La Jolla, CA 92037 USA
来源
JOURNAL OF EXPERIMENTAL MEDICINE | 1998年 / 187卷 / 08期
关键词
D O I
10.1084/jem.187.8.1261
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Early in programmed cell death (apoptosis), mitochondrial membrane permeability increases. This is at least in part due to opening of the permeability transition (PT) pore, a multiprotein complex built up at the contact site between the inner aid the outer mitochondrial membranes. The PT pore has been previously implicated in clinically relevant massive cell death induced by toxins, anoxia, reactive oxygen species, and calcium overload. Here we show that PT pore complexes reconstituted in liposomes exhibit a functional behavior comparable with that of the natural PT pore present in intact mitochondria. The PT pore complex is regulated by thiol-reactive agents, calcium, cyclophilin D ligands (cyclosporin A and a nonimmunosuppressive cyclosporin A derivative), ligands of the adenine nucleotide translocator, apoptosis-related endoproteases (caspases), and Bcl-2-like proteins. Although calcium, prooxidants, and several recombinant caspases (caspases 1, 2, 3, 4, and 6) enhance the permeability of PT pore-containing liposomes, recombinant Bcl-2 or Bcl-X-L augment the resistance of the reconstituted PT pore complex to pore opening. Mutated Bcl-2 proteins that have lost their cytoprotective potential also lose their PT modulatory capacity. In conclusion, the PT pore complex may constitute a crossroad of apoptosis regulation by caspases and members of the Bcl-2 family.
引用
收藏
页码:1261 / 1271
页数:11
相关论文
共 50 条
  • [1] Regulation of apoptosis: involvement of bcl-2-related proteins
    Motyl, T
    REPRODUCTION NUTRITION DEVELOPMENT, 1999, 39 (01): : 49 - 59
  • [2] Bcl-2-related survival proteins
    Schwartz, P. S.
    Hockenbery, D. M.
    CELL DEATH AND DIFFERENTIATION, 2006, 13 (08): : 1250 - 1255
  • [3] Bcl-2-related survival proteins
    P S Schwartz
    D M Hockenbery
    Cell Death & Differentiation, 2006, 13 : 1250 - 1255
  • [4] Bcl-2-related proteins and cancer
    MacCarthy-Morrogh, L
    Mouzakiti, A
    Townsend, P
    Brimmell, M
    Packham, G
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1999, 27 : 785 - 789
  • [5] Role of the BH3 (Bcl-2 homology 3) domain in the regulation of apoptosis and Bcl-2-related proteins
    Lutz, RJ
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2000, 28 : 51 - 56
  • [6] Role of Bcl-2 family proteins and caspases in the regulation of apoptosis
    Mohammad Shamsul Ola
    Mohd. Nawaz
    Haseeb Ahsan
    Molecular and Cellular Biochemistry, 2011, 351 : 41 - 58
  • [7] Role of Bcl-2 family proteins and caspases in the regulation of apoptosis
    Ola, Mohammad Shamsul
    Nawaz, Mohd
    Ahsan, Haseeb
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2011, 351 (1-2) : 41 - 58
  • [8] Bcl-2-related proteins as drug targets
    O'Neill, JW
    Hockenbery, DM
    CURRENT MEDICINAL CHEMISTRY, 2003, 10 (16) : 1553 - 1562
  • [9] Role of caspases 1 and 3 and Bcl-2-related molecules in endothelial cell apoptosis associated with thrombotic microangiopathies
    Mitra, D
    Kim, JY
    MacLow, C
    Karsan, A
    Laurence, J
    AMERICAN JOURNAL OF HEMATOLOGY, 1998, 59 (04) : 279 - 287
  • [10] Targeting Bcl-2-related proteins in cancer therapy
    Manion, MK
    Hockenbery, DM
    CANCER BIOLOGY & THERAPY, 2003, 2 (04) : S105 - S114